These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24575871)

  • 1. Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis.
    Lehnert S; Costa J; de Carvalho M; Kirby J; Kuzma-Kozakiewicz M; Morelli C; Robberecht W; Shaw P; Silani V; Steinacker P; Tumani H; Van Damme P; Ludolph A; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):344-50. PubMed ID: 24575871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.
    Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF
    BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of CSF NfL and tau in ALS.
    Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
    J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Underestimated Relevance of Alzheimer's Disease Copathology in Amyotrophic Lateral Sclerosis.
    Barba L; Otto M; Abu-Rumeileh S
    J Alzheimers Dis; 2023; 95(4):1401-1404. PubMed ID: 37807784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.
    Bourbouli M; Rentzos M; Bougea A; Zouvelou V; Constantinides VC; Zaganas I; Evdokimidis I; Kapaki E; Paraskevas GP
    Dement Geriatr Cogn Disord; 2017; 44(3-4):144-152. PubMed ID: 28848086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study.
    Zucchi E; Bedin R; Fasano A; Fini N; Gessani A; Vinceti M; Mandrioli J
    Neurodegener Dis; 2018; 18(5-6):255-261. PubMed ID: 30428468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystatin C in cerebrospinal fluid as a biomarker of ALS.
    Tsuji-Akimoto S; Yabe I; Niino M; Kikuchi S; Sasaki H
    Neurosci Lett; 2009 Mar; 452(1):52-5. PubMed ID: 19444952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis.
    Li S; Ren Y; Zhu W; Yang F; Zhang X; Huang X
    J Neurol Sci; 2016 Aug; 367():269-74. PubMed ID: 27423602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF markers in amyotrophic lateral sclerosis.
    Tarasiuk J; Kułakowska A; Drozdowski W; Kornhuber J; Lewczuk P
    J Neural Transm (Vienna); 2012 Jul; 119(7):747-57. PubMed ID: 22555610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
    Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
    J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS.
    Oeckl P; Jardel C; Salachas F; Lamari F; Andersen PM; Bowser R; de Carvalho M; Costa J; van Damme P; Gray E; Grosskreutz J; Hernández-Barral M; Herukka SK; Huss A; Jeromin A; Kirby J; Kuzma-Kozakiewicz M; Amador Mdel M; Mora JS; Morelli C; Muckova P; Petri S; Poesen K; Rhode H; Rikardsson AK; Robberecht W; Rodríguez Mahillo AI; Shaw P; Silani V; Steinacker P; Turner MR; Tüzün E; Yetimler B; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(5-6):404-13. PubMed ID: 27415180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis.
    Lanznaster D; Hergesheimer RC; Bakkouche SE; Beltran S; Vourc'h P; Andres CR; Dufour-Rainfray D; Corcia P; Blasco H
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.
    Ganesalingam J; An J; Shaw CE; Shaw G; Lacomis D; Bowser R
    J Neurochem; 2011 May; 117(3):528-37. PubMed ID: 21418221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum.
    Süssmuth SD; Tumani H; Ecker D; Ludolph AC
    Neurosci Lett; 2003 Dec; 353(1):57-60. PubMed ID: 14642437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.